SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 75 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $206,946 | +2.0% | 31,789 | +33.6% | 0.01% | -30.0% |
| Q4 2022 | $202,937 | +269.0% | 23,791 | +127.3% | 0.01% | +400.0% |
| Q3 2022 | $55,000 | +12.2% | 10,468 | -5.7% | 0.00% | +100.0% |
| Q2 2022 | $49,000 | +32.4% | 11,104 | +4.4% | 0.00% | 0.0% |
| Q1 2022 | $37,000 | -47.1% | 10,640 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $70,000 | -44.0% | 10,605 | -10.2% | 0.00% | -50.0% |
| Q3 2021 | $125,000 | -61.5% | 11,809 | +14.7% | 0.00% | -60.0% |
| Q2 2021 | $325,000 | -25.3% | 10,295 | -4.0% | 0.01% | -37.5% |
| Q1 2021 | $435,000 | – | 10,726 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $12,721,000 | 3.35% |
| Orbimed Advisors | 8,740,887 | $58,214,000 | 0.75% |
| Nantahala Capital Management | 1,006,462 | $6,703,000 | 0.24% |
| EcoR1 Capital, LLC | 1,060,010 | $7,060,000 | 0.22% |
| Prosight Management, LP | 53,815 | $358,000 | 0.21% |
| RA Capital Management | 1,742,186 | $11,603,000 | 0.20% |
| Endurant Capital Management LP | 84,295 | $561,000 | 0.14% |
| HighVista Strategies LLC | 22,434 | $149,000 | 0.12% |
| XTX Topco Ltd | 18,816 | $125,000 | 0.07% |
| WASATCH ADVISORS LP | 1,773,690 | $11,813,000 | 0.05% |